Try a new search

Format these results:

Searched for:

in-biosketch:true

person:simsia01

Total Results:

163


Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?

Brandler, Tamar C; Zhou, Fang; Liu, Cheng Z; Cho, Margaret; Lau, Ryan P; Simsir, Aylin; Patel, Kepal N; Sun, Wei
BACKGROUND: Noninvasive encapsulated follicular variant of papillary thyroid carcinoma, a diagnosis implying malignancy as a variant of papillary thyroid carcinoma (PTC), has recently been reclassified to noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) on surgical pathology. Due to the effects of such a recategorization on rate of malignancy and clinical management algorithms, it is imperative that we explore whether presurgical fine-needle aspiration can differentiate NIFTP from PTC and follicular adenoma (FA). METHODS: Cytology slides from subjects with final surgical pathology resection diagnoses of NIFTP/encapsulated follicular variant of papillary thyroid carcinoma, classic PTC, and FA made between January 2013 and August 2016 were assessed. The Bethesda System diagnoses were tabulated and cytomorphologic features were analyzed for an association with surgical pathology diagnoses. RESULTS: A total of 56 NIFTP, 67 classic PTC, and 30 FA cases were included. The presurgical NIFTP diagnosis according to The Bethesda System was most often atypia of undetermined significance (37.5%) followed by suspicious for follicular neoplasm/follicular neoplasm (26.8%), suspicious for malignancy (17.9%), benign (10.7%), and positive for malignancy (7.1%). The most common NIFTP cytomorphologic features were nuclear enlargement (83.9%), nuclear crowding (82.1%), nuclear clearing (69.6%), and microfollicles (73.2%). All cytomorphologic features demonstrated statistically significant associations (P value range, <.001-.002) between NIFTP and PTC, whereas select cytomorphologic features demonstrated significant associations between NIFTP and FA. CONCLUSIONS: Several statistically significant associations appear to be present between cytomorphologic features and surgical diagnosis that may be used as clues to distinguish NIFTP, PTC, and FA on fine-needle aspiration. Although diagnostic confirmation of NIFTP must occur at the time of excision, similar to follicular neoplasms, the possibility of NIFTP may be raised preoperatively on cytology. Cancer Cytopathol 2017;125:378-88. (c) 2017 American Cancer Society.
PMID: 28296267
ISSN: 1097-0142
CID: 2593342

Live Digital Telepathology Enables Rapid Remote Frozen Section Diagnosis and Cytology Adequacy Assessment by Subspecialists [Meeting Abstract]

Kane, Yehonatan; Darvishian, Farbod; Deng, Fang-Ming; Moreira, Andre L; Simsir, Aylin; William, Christopher; Snuderl, Matija
ISI:000393724402076
ISSN: 1530-0307
CID: 2506802

Can Noninvasive Follicular Thyroid Neoplasm with Papillary Like Nuclear Features (NIFTP) and Classical Papillary Thyroid Carcinoma (PTC) Be Distinguished by Fine Needle Aspiration (FNA)? [Meeting Abstract]

Brandler, Tamar C; Zhou, Fang; Cho, Margaret; Lau, Ryan P; Liu, Cheng; Simsir, Aylin; Patel, Kepal N; Sun, Wei
ISI:000393724400343
ISSN: 1530-0307
CID: 2506612

Impact of the Reclassification of Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma (EFVPTC) to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on the Current Management Guidelines of the Bethesda System for Reporting Thyroid Cytopathology [Meeting Abstract]

Lau, Ryan P; Paulsen, John D; Brandler, Tamar C; Simsir, Aylin; Zhou, Fang
ISI:000393724400397
ISSN: 1530-0307
CID: 2506632

Can Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) and Classical Papillary Thyroid Carcinoma (PTC) Be Distinguished by Fine Needle Aspiration (FNA)? [Meeting Abstract]

Brandler, Tamar C; Zhou, Fang; Cho, Margaret; Lau, Ryan P; Liu, Cheng; Simsir, Aylin; Patel, Kepal N; Sun, Wei
ISI:000394467300343
ISSN: 1530-0285
CID: 2517432

Impact of the Reclassification of Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma (EFVPTC) to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on the Current Management Guidelines of the Bethesda System for Reporting Thyroid Cytopathology [Meeting Abstract]

Lau, Ryan P; Paulsen, John D; Brandler, Tamar C; Simsir, Aylin; Zhou, Fang
ISI:000394467300397
ISSN: 1530-0285
CID: 2517452

Live Digital Telepathology Enables Rapid Remote Frozen Section Diagnosis and Cytology Adequacy Assessment by Subspecialists [Meeting Abstract]

Kane, Yehonatan; Darvishian, Farbod; Deng, Fang-Ming; Moreira, Andre L; Simsir, Aylin; William, Christopher; Snuderl, Matija
ISI:000394467302170
ISSN: 1530-0285
CID: 2517622

"Low-grade squamous intraepithelial lesion, cannot exclude high-grade:" TBS says "Don't Use It!" should I really stop it?

Chiaffarano, Jeanine M; Alexander, Melissa; Rogers, Robert; Zhou, Fang; Cangiarella, Joan; Yee-Chang, Melissa; Elgert, Paul; Simsir, Aylin
BACKGROUND: The Bethesda System uses a two-tiered approach in the diagnosis of cervical squamous intraepithelial lesions (SILs). Occasionally, Papanicolaou (Pap) tests with evident low-grade SIL (LSIL) also have some features suggestive but not diagnostic of high-grade SIL (HSIL). This study reviews our experience with "Low-grade Squamous Intraepithelial Lesion, Cannot Exclude High-grade" (LSIL-H) and discusses the best approach to report such Paps if the LSIL-H interpretation is abandoned. METHODS: Abnormal Paps were identified between January and December 2014 that had surgical follow-up within 6 months. Their biopsy outcomes were compared. Statistical analysis was performed using Pearson's Chi-square and McNemar tests in SPSS software version 23. Statistical significance was defined as P
PMCID:5458421
PMID: 28603542
ISSN: 1742-6413
CID: 2593522

Low grade squamous intraepithelial Lesion, Cannot Exclude High Grade (LSIL-H): TBS says don't use it. Should i really stop it? [Meeting Abstract]

Chiaffarano, J; Alexander, M; Elgert, P A; Yee-Chang, M; Zhou, F; Simsir, A
Introduction: The Bethesda System (TBS) uses a two-tiered approach to cervical squamous intraepithelial lesions (SILs). Occasionally, Paps with evident low grade SIL (LSIL) also have some features suggestive but not diagnostic of high grade SIL (HSIL). These Paps in our and other institutions are reported as 'LSIL, Cannot Exclude HSIL' (LSIL-H). LSIL-H has been shown to represent an intermediate risk (between LSIL and HSIL) for harboring a high grade lesion/carcinoma (HGD+) on biopsy. However, TBS 2014 continues to discourage its use to prevent the re-emergence of a threetiered reporting system. We review our experience with LSIL-H and discuss the best approach to report such Paps if the LSIL-H category is abandoned. Materials and Methods: Abnormal Paps were identified between January and June 2014 which had surgical follow-up within six months. Their biopsy outcomes were compared. Statistical analysis was performed using the Fisher's exact test. Results: Table 1 summarizes surgical diagnoses for each abnormal Pap category (total n=571). The differences in detection rates of HGD+ between LSIL and LSIL-H Pap was significant (p=0.000), whereas between LSIL-H and 'Atypical squamous cells, cannot exclude HSIL' (ASC-H) was not (p=0.101). If the LSIL-Hcategory is abandoned and LSIL-Hcases are reported as ASC-H, the rate ofHGD+ for theASC-H categorywould decrease from 55% to 41% (p=0.3). Alternatively, if LSIL-H cases are downgraded to LSIL, the rate of HGD+ for the LSIL category would rise from 7% to 9% (p=0.27). Conclusions: The 'LSIL-H' category indeed detects more HGD+ than LSIL, and fewer HGD+ than ASC-H. If LSIL-H is eliminated, Paps with this finding are best reported as ASC-H to ensure that women with potential HGD+ undergo colposcopy in a timely manner. Reporting LSIL-H as LSIL may delay colposcopy since management of LSIL Pap depends on multiple factors (age, HPV status, etc). (Table Presented)
EMBASE:615337482
ISSN: 2213-2945
CID: 2620182

P40 and P63 in the diagnosis of pulmonary non-small cell carcinoma: Can P40 really replace P63 in cytology? [Meeting Abstract]

Simsir, A; Alexander, M; Chiaffarano, J; Yee-Chang, M
Introduction: Differentiating squamous cell carcinoma (SCC) from adenocarcinoma (ACA) can be challenging in cytology specimens. This distinction has major implications for lung carcinomas. We've been utilizing p63, and for the last 2 years, its n-terminally truncated variant, p40, to identify squamous differentiation. Recent literature showed p40 to have a better specificity for this purpose. We evaluated our experience to determine if p63 can be eliminated from our diagnostic panel to maximize cost savings and tissue preservation in cell blocks. Materials and Methods: 115 cytology cases of pulmonary ACAs and SCCs were identified with both p40 and p63 staining. All IHC was performed on cell blocks. Slides were scored for intensity and extent of staining using a 0- 3+ scale (intensity: 0, none; 3+, equivalent to positive control; extent/ percent of tumor cells staining: 0: none; 1+: 1-25%; 2+: 25-50%; and 3+: 50-100%). Results: Table 1 depicts our results. All SCCs and adenosquamous carcinomas (100%) were positive for both p40 and p63 regardless of specimen site. Overall, 15% of ACAs were positive for p40, and 16% were positive for p63, regardless of specimen site. Eleven percent (11%) of ACAs were positive for p40 in lung FNAs, and 21% were positive for p63. ACAs in effusion specimens resulted in more cases with p40 positivity (28%) compared to lung FNAs; this was not the case for p63 (21% in lung FNAs versus 11% in effusions). Conclusions: Our results demonstrate that p40 and p63 antibodies stain all SCCs in cytology specimens. However, despite prior reports claiming superior results for p40, we found that p40 yields a discernible level of false positivity in lung ACAs similar to p63. False positive rate for p40 in ACAs is highest in effusions and is not negligible. Therefore, it is not clear if p40 is preferable to p63 in cytology specimens. (Table Presented)
EMBASE:615337405
ISSN: 2213-2945
CID: 2620192